153 related articles for article (PubMed ID: 36626512)
1. Prognostic influence for hilar cholangiocarcinoma and comparisons of prognostic values of Mayo staging and TNM staging systems.
Sun Z; Sun X; Guo J; Li X; Wang Q; Su N; Chen M; Cao G; Yu Y; Wang M; Li H; Zhong H; Zou H; Ma K; Shen F; Zhang B; Sun X; Feng Y
Medicine (Baltimore); 2022 Dec; 101(49):e32250. PubMed ID: 36626512
[TBL] [Abstract][Full Text] [Related]
2. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
3. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
Ding G; Yang Y; Cao L; Chen W; Wu Z; Jiang G
World J Surg Oncol; 2015 Mar; 13():99. PubMed ID: 25889726
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the Predictive Values of Eight Staging Systems for Primary Liver Cancer in Prognosis of Combined Hepatocellular-cholangiocellular Carcinoma Patients after Surgery].
Li H; Wang XT; Zhang AQ; Meng XF; Yu Q; Lü WP; Duan WD; Dong JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):175-81. PubMed ID: 27181894
[TBL] [Abstract][Full Text] [Related]
6. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes.
Conci S; Ruzzenente A; Sandri M; Bertuzzo F; Campagnaro T; Bagante F; Capelli P; D'Onofrio M; Piccino M; Dorna AE; Pedrazzani C; Iacono C; Guglielmi A
Eur J Surg Oncol; 2017 Apr; 43(4):743-750. PubMed ID: 28094085
[TBL] [Abstract][Full Text] [Related]
7. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma.
Coelen RJS; Gaspersz MP; Labeur TA; van Vugt JLA; van Dieren S; Willemssen FEJA; Nio CY; IJzermans JNM; Klümpen HJ; Groot Koerkamp B; van Gulik TM
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1930-1939.e3. PubMed ID: 28532698
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.
Lee JW; Lee JH; Park Y; Lee W; Kwon J; Song KB; Hwang DW; Kim SC
Cancer Res Treat; 2020 Jul; 52(3):886-895. PubMed ID: 32164049
[TBL] [Abstract][Full Text] [Related]
11. Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma.
Li B; Lu J; Peng DZ; Zhang XY; You Z
Medicine (Baltimore); 2020 Mar; 99(12):e19400. PubMed ID: 32195935
[TBL] [Abstract][Full Text] [Related]
12. The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer.
Liu C; Zhang H; Qi Q; Zhang B; Yue D; Wang C
Thorac Cancer; 2020 Apr; 11(4):918-927. PubMed ID: 32061027
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic parameters measured by pretreatment dual-time-point 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study.
Hwang JP; Moon JH; Kim HK; Lee MH; Lim CH; Park SB; Yoon JK; Park JM
Medicine (Baltimore); 2021 May; 100(21):e26015. PubMed ID: 34032720
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Li O; Yi W; Yang P; Guo C; Peng C
Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.
Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS
World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213
[TBL] [Abstract][Full Text] [Related]
16. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
17. The DNA index as a prognostic tool in hilar cholangiocarcinoma.
Kamphues C; Al-Abadi N; Bova R; Rademacher S; Al-Abadi H; Klauschen F; Bahra M; Neuhaus P; Pratschke J; Seehofer D
J Surg Oncol; 2015 Aug; 112(2):214-8. PubMed ID: 26220797
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
